Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Abroad (travel likely)RecruitingPHASE1

Conditions

Solid Tumor (Excluding CNS) · Liver Cell Carcinoma · Malignant Rhabdoid Tumor · Yolk Sac Tumor · Liposarcoma · Rhabdomyosarcoma · Embryonal Sarcoma of Liver · Wilms Tumor · Hepatocellular Carcinoma · Hepatoblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Michelle Choe, MD) · michelle.choe@seattlechildrens.org · 206-987-2106
Contact: Study coordinator (Andras Heczey, MD) · andras.heczey@seattlechildrens.org
Contact: Principal Investigator (Michelle Choe, MD)

Study leads

Colleen Annesley, MD
Study Director
Seattle Children's Hospital
Corinne Summers, MD
Study Director
Seattle Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology

Solid Tumor (Excluding CNS)

Abroad (travel likely)Recruiting

Lyon, France · Lyon, France